| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 10, 2003
Revised on June 11, 2003
Accepted on June 26, 2003
From the Departments of Molecular Medicine (Y.N., M.I., K.T., Y.O., S.S., K.Y.-T., I.K., H.H.) and Molecular Oncology (T.H.), Osaka University Graduate School of Medicine, Osaka, Japan; Laboratory for Cytokine Signaling (K.N., T.H.), RIKEN Research Center for Allergy and Immunology, Kanagawa, Japan; Department of Clinical Evaluation of Medicines and Therapeutics (Y.F.), Osaka University Graduate School of Pharmaceutical Sciences, Osaka, Japan; Department of Microbiology and Immunology (S.M., S.K.), Keio University School of Medicine, Tokyo, Japan; and Laboratory for Developmental Immunology (T.H.), Osaka University Graduate School of Frontier Bioscience, Osaka, Japan.
* To whom correspondence should be addressed. E-mail: hirota{at}imed3.med.osaka-u.ac.jp.
Grb2-associated binder-1 (Gab1) is a scaffolding/docking protein and contains a Pleckstrin homology domain and potential binding sites for Src homology (SH) 2 and SH3 domains. Gab1 is tyrosine phosphorylated and associates with protein tyrosine phosphatase SHP2 and p85 phosphatidylinositol 3-kinase on stimulation with various cytokines and growth factors, including interleukin-6. We previously demonstrated that interleukin-6-related cytokine, leukemia inhibitory factor (LIF), induced cardiac hypertrophy through gp130. In this study, we report the role of Gab1 in gp130-mediated cardiac hypertrophy. Stimulation with LIF induced tyrosine phosphorylation of Gab1, and phosphorylated Gab1 interacted with SHP2 and p85 in cultured cardiomyocytes. We constructed three kinds of adenovirus vectors, those carrying wild-type Gab1 (AdGab1WT), mutated Gab1 lacking SHP2 binding site (AdGab1F627/659), and
-galactosidase (Ad
-gal). Compared with cardiomyocytes infected with Ad
-gal, longitudinal elongation of cardiomyocytes induced by LIF was enhanced in cardiomyocytes infected with AdGab1WT but inhibited in cardiomyocytes infected with AdGab1F627/659. Upregulation of BNP mRNA expression by LIF was evoked in cardiomyocytes infected with Ad
-gal and AdGab1WT but not in cardiomyocytes infected with AdGab1F627/659. In contrast, Gab1 repressed skeletal
-actin mRNA expression through interaction with SHP2. Furthermore, activation of extracellular signal-regulated kinase 5 (ERK5) was enhanced in cardiomyocytes infected with AdGab1WT compared with cardiomyocytes infected with Ad
-gal but repressed in cardiomyocytes infected with AdGab1F627/659. Coinfection of AdGab1WT with adenovirus vector carrying dominant-negative ERK5 abrogated longitudinal elongation of cardiomyocytes induced by LIF. Taken together, these findings indicate that Gab1-SHP2 interaction plays a crucial role in gp130-dependent longitudinal elongation of cardiomyoctes through activation of ERK5.
This article has been cited by other articles:
![]() |
M. Kurdi and G. W. Booz JAK redux: a second look at the regulation and role of JAKs in the heart Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1545 - H1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Martin and J. Hwa Shp Shape: FAKs About Hypertrophy Circ. Res., October 10, 2008; 103(8): 776 - 778. [Full Text] [PDF] |
||||
![]() |
T. Koyama, Y. Nakaoka, Y. Fujio, H. Hirota, K. Nishida, S. Sugiyama, K. Okamoto, K. Yamauchi-Takihara, M. Yoshimura, S. Mochizuki, et al. Interaction of Scaffolding Adaptor Protein Gab1 with Tyrosine Phosphatase SHP2 Negatively Regulates IGF-I-dependent Myogenic Differentiation via the ERK1/2 Signaling Pathway J. Biol. Chem., August 29, 2008; 283(35): 24234 - 24244. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujii, S. Matsuda, G. Takayama, and S. Koyasu ERK5 is involved in TCR-induced apoptosis through the modification of Nur77. Genes Cells, May 1, 2008; 13(5): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang Mitogen-Activated Protein Kinases in Heart Development and Diseases Circulation, September 18, 2007; 116(12): 1413 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosario, R. Franke, C. Bednarski, and W. Birchmeier The neurite outgrowth multiadaptor RhoGAP, NOMA-GAP, regulates neurite extension through SHP2 and Cdc42 J. Cell Biol., July 24, 2007; 178(3): 503 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Coles, C. A. Fielding, S. Rose-John, J. Scheller, S. A. Jones, and V. B. O'Donnell Classic Interleukin-6 Receptor Signaling and Interleukin-6 trans-Signaling Differentially Control Angiotensin II-Dependent Hypertension, Cardiac Signal Transducer and Activator of Transcription-3 Activation, and Vascular Hypertrophy in Vivo Am. J. Pathol., July 1, 2007; 171(1): 315 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rafiq, M. A. Kolpakov, M. Abdelfettah, D. N. Streblow, A. Hassid, L. J. Dell'Italia, and A. Sabri Role of Protein-tyrosine Phosphatase SHP2 in Focal Adhesion Kinase Down-regulation during Neutrophil Cathepsin G-induced Cardiomyocytes Anoikis J. Biol. Chem., July 14, 2006; 281(28): 19781 - 19792. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-D. Tang, J. A. Kuzman, S. Said, B. E. Anderson, X. Wang, and A. M. Gerdes Low Thyroid Function Leads to Cardiac Atrophy With Chamber Dilatation, Impaired Myocardial Blood Flow, Loss of Arterioles, and Severe Systolic Dysfunction Circulation, November 15, 2005; 112(20): 3122 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, K.-i. Aihara, T. Sato, M. Akaike, M. Yoshizumi, Y. Suzaki, Y. Izawa, M. Fujimura, S. Hashizume, M. Kato, et al. Androgen Receptor Gene Knockout Male Mice Exhibit Impaired Cardiac Growth and Exacerbation of Angiotensin II-induced Cardiac Fibrosis J. Biol. Chem., August 19, 2005; 280(33): 29661 - 29666. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang Fill a Gab(1) in Cardiac Hypertrophy Signaling: Search a Missing Link Between gp130 and ERK5 in Hypertrophic Remodeling in Heart Circ. Res., August 8, 2003; 93(3): 186 - 188. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |